OR WAIT null SECS
August 01, 2014
Experts from contract testing laboratories and service organizations shared their perceptions of analytical testing advances, and challenges still ahead.
Representatives of contract service organizations that specialize in parenteral drug development and manufacturing describe the evolving trends.
Despite the growth of specialist companies with capabilities across various therapeutic areas in Europe, there is still a need for early development expertise with end-to-end pharmaceutical manufacturing capabilities.
Contract development and manufacturing organizations identify trends, challenges, and emerging technology and service needs for solid and semi-solid dosage forms.
For a bio/pharma industry in flux, contract services are playing a greater-and more diverse-role in drug development.
July 16, 2014
Hovione will use Merrion's GIPET absorption-enhancing technology for solid-dosage drugs.
June 29, 2014
PharmSource special report shows demand for cytotoxic injectable drugs could tap existing CMO capacity.
May 02, 2014
Biopharma companies should not overlook India's growing market.
April 02, 2014
The international pharmaceutical industry is changing its approach to R&D and is increasingly relying on outsourcing for drug discovery.
February 02, 2014
CMOs may find opportunities in alternative expression services.